BROWSE·page 1022 of 1443

Browse EX-10 agreements

17,311 total material contract exhibits.


EX-10.1

CENTRAL PACIFIC FINANCIAL CORP

Document

CENTRAL PACIFIC FINANCIAL CORP. CENTRAL PACIFIC BANK CHANGE IN CONTROL AGREEMENT

THIS AGREEMENT is made     and entered into this _____ day of June, 2026 (the “Effective Date”), by and between Central Pacific Financial Corporation (“CPFC”) and Central Pacific Bank (the “Bank” and together with CPFC, the “Company”), and Arnold D. Martines (“Executive”), with reference to the following:

A.    Executive currently is employed by the Company as Chairman, President and Chief Executive Officer. Executive is an experienced and knowledgeable individual whose creativity, expertise and effort have assisted in the development of the business and growth of the Company.

…

EX-10.1·8-K·CIK 701347·ACC 0000701347-26-000063·Filed Jul 02, 2026, 16:26 ET

EX-10.1

KKR Private Equity Conglomerate LLC

Document

Exhibit 10.1

SECOND AMENDED AND RESTATED MANAGEMENT AGREEMENT

by and between

KKR Private Equity Conglomerate LLC

and

KKR DAV Manager LLC


AMENDED AND RESTATED MANAGEMENT AGREEMENT, dated as of July 2, 2026, by and between KKR Private Equity Conglomerate LLC, a Delaware limited liability company, and KKR DAV Manager LLC, a Delaware limited liability company (the “Manager”).

WHEREAS, the Company was formed as a limited liability company and intends to elect to be treated as a partnership for U.S. federal income tax purposes pursuant to the Internal Revenue Code of 1986, as amended (the “Code”);

WHEREAS, the Company and the Manager entered into a Management Agreement, dated as of July 27, 2023 (the “Original Agreement”);

WHEREAS, the Company and the Manager entered into an Amended and Restated Management Agreement, dated as of May 30, 2024, which amended and restated the Original Agreement in its entirety (the “A&R Agreement”);

WHEREAS, the Company and the Manager desire to amend and restate the A&R Agreement;

…

EX-10.1·8-K·CIK 1957845·ACC 0001957845-26-000060·Filed Jul 02, 2026, 16:24 ET

EX-10.2

KKR Private Equity Conglomerate LLC

Document

Exhibit 10.2

AMENDED AND RESTATED DEALER-MANAGER AGREEMENT

THIS AMENDED AND RESTATED DEALER-MANAGER AGREEMENT (this “Agreement’) is made as of this 2nd day of July, 2026, by and between KKR Private Equity Conglomerate LLC, a Delaware limited liability company (the “Company”), and KKR Capital Markets LLC (the “Dealer-Manager”), a Delaware limited liability company.

WHEREAS, the Company is conducting a private placement offering in accordance with Rule 506(b) of Regulation D and Regulation S under the Securities Act of 1933, as amended (the “1933 Act”), of the classes of shares (the “Shares”) listed in the Company’s private placement memorandum in connection with such private placement offering (as amended and supplemented from time to time, the “Private Placement Memorandum”);

WHEREAS, the Company has filed a registration statement with the U.S. Securities and Exchange Commission (the “SEC”) pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended (the “1934 Act”);

…

EX-10.2·8-K·CIK 1957845·ACC 0001957845-26-000060·Filed Jul 02, 2026, 16:24 ET

EXHIBIT 10.1

BridgeBio Pharma, Inc.


Exhibit 10.1

EXECUTION VERSION

 

CERTAIN INFORMATION IDENTIFIED BY “[***]” HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

 

INVESTMENT AGREEMENT

 

dated as of July 1, 2026

 

by and among

 

BridgeBio Pharma, Inc.

 

and

 

the Purchasers identified herein

 


TABLE OF CONTENTS

 

 

Page

 

 

 

ARTICLE I

 

PURCHASE; CLOSING

 

 

 

Section 1.1

Purchase

1

Section 1.2

Closing

1

 

 

 

ARTICLE II

 

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

 

 

Section 2.1

Organization and Authority

2

Section 2.2

Capitalization

2

Section 2.3

Authorization

3

Section 2.4

Sale and Status of Securities

4

Section 2.5

SEC Documents; Financial Statements

5

Section 2.6

Undisclosed Liabilities

5

Section 2.7

Absence of Changes

5

Section 2.8

Brokers and Finders

6

Section 2.9

Registration Rights

6

Section 2.10

Compliance with Laws; Anti-Corruption; Trade Controls

6

Section 2.11

Listing and Maintenance Requirements

7

…

EX-10.1·8-K·CIK 1743881·ACC 0001140361-26-027445·Filed Jul 02, 2026, 16:23 ET

EXHIBIT 10.2

BridgeBio Pharma, Inc.


Exhibit 10.2

EXECUTION VERSION

 

 REGISTRATION RIGHTS AGREEMENT

 

of

 

BridgeBio Pharma, Inc.

 

dated as of July 1, 2026

 


TABLE OF CONTENTS

 

 

 

 

Page

 

 

 

 

Definitions

1

Registration Rights

4

 

(a)

Shelf Registration

4

 

(b)

Automatic Shelf Registration Statements

4

 

(c)

Continued Effectiveness

4

 

(d)

Postponements in Requested Registrations

4

 

(e)

Registration Expenses

4

Registration Procedures

5

Indemnification

8

 

(a)

Indemnification by the Company

8

 

(b)

Indemnification by the Stockholders of Registrable Securities

8

 

(c)

Conduct of Indemnification Proceedings

9

 

(d)

Contribution

9

 

(e)

Non-Exclusivity

10

Registration Expenses

10

Rule 144

10

Miscellaneous

10

 

(a)

Termination

10

 

(b)

Amendments and Waivers

11

 

(c)

Successors, Assigns and Transferees

11

 

(d)

Notices

11

 

(e)

Further Assurances

12

 

(f)

No Inconsistent Agreements

12

 

(g)

Entire Agreement; No Third Party Beneficiaries

12

 

(h)

…

EX-10.2·8-K·CIK 1743881·ACC 0001140361-26-027445·Filed Jul 02, 2026, 16:23 ET

VOTING AND SUPPORT AGREEMENT

 

This VOTING AND SUPPORT AGREEMENT (this “Agreement”), is dated as of June , 2026, by and among Columbus Circle Capital Corp. II, a Cayman Islands exempted company (which shall domesticate as a Delaware corporation prior to the Closing) (the “Purchaser”), the Persons set forth on Schedule I hereto (the “Sellers”) and Elroy Air, Inc., a Delaware corporation (the “Company”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined below).

 

WHEREAS, as of the date hereof, the Sellers are the holders of such number and type of Company Securities as are indicated opposite each of their names on Schedule I attached hereto (collectively, the “Subject Securities”);

…

EX-10.2·425·CIK 2088805·ACC 0001213900-26-075001·Filed Jul 02, 2026, 16:22 ET

FORM OF SPONSOR LOCK-UP AGREEMENT

Columbus Circle Capital Corp II

LOCK-UP AGREEMENT

 

THIS LOCK-UP AGREEMENT (this “Agreement”), dated as of [●], 2026, is made and entered into by and among Elroy Air, Inc., a Delaware corporation (the “Company”) (formerly known as Inflection Point Acquisition Corp. VII, a Cayman Islands exempted company, prior to its domestication as a Delaware corporation), Columbus Circle 2 Sponsor Corporation LLC, a Delaware limited liability company (the “Sponsor”), Cohen & Company Securities, LLC (“CCM”) and Clear Street LLC (“Clear Street”) and, the Sponsor, CCM and Clear Street, together with any Person who hereafter becomes a party to this Agreement pursuant to Section 2 or Section 7 of this Agreement, (the “Securityholders” and each, a “Securityholder”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined herein).

…

EX-10.3·425·CIK 2088805·ACC 0001213900-26-075001·Filed Jul 02, 2026, 16:22 ET

FORM OF SECURITIES PURCHASE AGREEMENT

Columbus Circle Capital Corp II

Execution Version

SECURITIES PURCHASE AGREEMENT

 

This Securities Purchase Agreement (this “Agreement”) is dated as of June 26, 2026, by and among Columbus Circle Capital Corp. II, a Cayman Islands exempted company (the “Company”), Elroy Air, Inc., a Delaware corporation (the “Target”), and the purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”).

WHEREAS, the Company, the Target, and IPGX Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Merger Sub”), entered into a Business Combination Agreement, dated as of June 26, 2026 (as it may be amended, modified, supplemented or otherwise modified from time to time in accordance with its terms, the “Business Combination Agreement,” and the transactions contemplated by the Business Combination Agreement, the “Business Combination”), pursuant to which, among other things, the Target will merge with and into Merger Sub, with the Target surviving the merger as a wholly owned subsidiary of the Company;

…

EX-10.6·425·CIK 2088805·ACC 0001213900-26-075001·Filed Jul 02, 2026, 16:22 ET

FORM OF ELROY AIR LOCK-UP AGREEMENT

Columbus Circle Capital Corp II

FORM OF SELLER LOCK-UP AGREEMENT

 

THIS LOCK-UP AGREEMENT (this “Agreement”), dated as of [●], is made and entered into by and among [Elroy Air, Inc.]1, a Delaware corporation (the “Company”) (formerly known as Columbus Circle Capital Corp II, a Cayman Islands exempted company, prior to its domestication as a Delaware corporation), and the Persons set forth on Schedule I hereto (such Persons, together with any Person who hereafter becomes a party to this Agreement pursuant to Section 2 or Section 7 of this Agreement, the “Securityholders” and each, a “Securityholder”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined herein).

…

EX-10.4·425·CIK 2088805·ACC 0001213900-26-075001·Filed Jul 02, 2026, 16:22 ET

SPONSOR SUPPORT AGREEMENT

 

This Sponsor Support Agreement (this “Agreement”) is dated as of June 26, 2026, by and among Columbus Circle 2 Sponsor Corporation LLC, a Delaware limited liability company (the “Sponsor”), Columbus Circle Capital Corp. II, a Cayman Islands exempted company limited by shares (the “Purchaser”), and Elroy Air, Inc., a Delaware corporation (the “Company”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined below).

 

WHEREAS, as of the date hereof, the Sponsor is the holder of record and the “beneficial owner” (within the meaning of Rule 13d-3 under the Exchange Act) of (i) 265,000 Purchaser Class A Ordinary Shares (the Purchaser Class A Ordinary Shares are included in units, each unit consisting of one Purchaser Class A Ordinary Share and one-third of one warrant) and (ii) 7,666,667 Purchaser Class B Ordinary Shares (collectively, the “Subject Securities”);

…

EX-10.1·425·CIK 2088805·ACC 0001213900-26-075001·Filed Jul 02, 2026, 16:22 ET

FORM OF AMENDED AND RESTATED

REGISTRATION RIGHTS AGREEMENT

 

THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of [●], 2026, is made and entered into by and among Elroy Air, Inc., a Delaware corporation (formerly known as Inflection Point Acquisition Corp. VII, a Cayman Islands exempted company, prior to the Domestication (as defined herein)) (the “Company”), Columbus Circle 2 Sponsor Corporation LLC, a Delaware limited liability company (the “Sponsor”), the members of the Sponsor identified on the signature pages hereto under “Other Sponsor Holders” (such members, together with the Sponsor, the “Sponsor Holders”), each of the undersigned parties listed on the signature page hereto under “PIPE Holders” (the “PIPE Holders”), each of the undersigned parties listed on the signature page hereto under “Elroy Holders” (the “Elroy Holders”) and each of the undersigned parties listed on the signature page hereto under “Other Holders” (the “Other Holders” and each such party, together with the Sponsor,

…

EX-10.5·425·CIK 2088805·ACC 0001213900-26-075001·Filed Jul 02, 2026, 16:22 ET

EX-10.1

Pyxis Oncology, Inc.

SECURITIES PURCHASE AGREEMENT

BY AND AMONG

PYXIS ONCOLOGY, INC.,

AND

THE PURCHASERS

AS SET FORTH HEREIN

June 30, 2026

 

 

 

 

 

 

 

 

 

 

 

 


TABLE OF CONTENTS

Definitions

1

Purchase and Sale of Securities

6

2.1

Purchase and Sale

6

2.2

Closing

6

Representations and Warranties of the Company

7

3.1

Organization and Power

7

3.2

Capitalization

7

3.3

Registration Rights

7

3.4

Authorization

7

3.5

Valid Issuance

8

3.6

No Conflict

8

3.7

Consents

9

3.8

SEC Filings; Financial Statements

9

3.9

Absence of Changes

10

3.10

Absence of Litigation

10

3.11

Compliance with Law; Permits

10

3.12

Intellectual Property

11

3.13

Employee Benefits

11

3.14

Taxes

12

3.15

Environmental Laws

12

3.16

Title

12

3.17

Insurance

13

3.18

Nasdaq Stock Market

13

3.19

Sarbanes-Oxley Act

13

3.20

Clinical Data and Regulatory Compliance

13

3.21

Compliance with Health Care Laws

14

3.22

Accounting Controls and Disclosure Controls and Procedures

15

3.23

Price Stabilization of Common Stock

15

3.24

…

EX-10.1·8-K·CIK 1782223·ACC 0001193125-26-294613·Filed Jul 02, 2026, 16:20 ET